A "hybrid" immune system approach may prevent or cure Type 1 diabetes (T1D) by combining blood stem cell and islet cell transplants. The method uses a nonmyeloablative conditioning regimen to prevent ...
Discover the essential role of TGF-Beta 1 in cellular regulation, its signaling pathway, and how TGF-β1 antibodies are used ...
Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...
The Stanford researchers developed a surgical strike to replace the nuke. They used an antibody called anti-CD117 to target ...
Researchers at Mount Sinai Health System in New York and City of Hope in Los Angeles have developed a therapy that promises to not only improve symptoms of diabetes but also has the potential to ...
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold ...
A vascularized organoid model of hormone-secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies. “Our results highlight the importance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback